TerrAscend (TSNDF) Accounts Payables (2021 - 2026)
TerrAscend (TSNDF) reported Accounts Payables of $40.0 million for Q1 2026, down 9.57% year-over-year from $44.2 million in Q1 2025, and little changed quarter-over-quarter from $39.8 million in Q4 2025.
TerrAscend (TSNDF) Accounts Payables (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Accounts Payables data on file, last reported at $40.0 million in Q1 2026.
- Accounts Payables for Q1 2026 came in at $40.0 million, down 9.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.0 million (down 9.57% YoY), and the FY2025 annual result was $39.8 million, down 1.34% from the prior year.
- Accounts Payables steadied at $40.0 million in Q1 2026 per TSNDF's latest filing, from $39.8 million in the prior quarter.
- Over five years, Accounts Payables peaked at $61.7 million in Q3 2022 and troughed at $36.0 million in Q3 2025.
- A 5-year average of $46.8 million and a median of $46.9 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables surged 58.6% in 2022, then retreated 22.4% in 2025.
- A 5-year view of Accounts Payables shows it stood at $44.3 million in 2022, then advanced by 12.67% to $49.9 million in 2023, then fell by 19.14% to $40.3 million in 2024, then dropped by 1.34% to $39.8 million in 2025, then rose by 0.43% to $40.0 million in 2026.
- Business Quant data shows TSNDF's Accounts Payables at $40.0 million in Q1 2026, $39.8 million in Q4 2025, and $36.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | 39.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.98 Mn |
| Dec 31, 2025 | 39.81 Mn |
| Sep 30, 2025 | 35.99 Mn |
| Jun 30, 2025 | 37.01 Mn |
| Mar 31, 2025 | 44.21 Mn |
| Dec 31, 2024 | 40.35 Mn |
| Sep 30, 2024 | 46.38 Mn |
| Jun 30, 2024 | 46.92 Mn |
| Mar 31, 2024 | 49.67 Mn |
| Dec 31, 2023 | 49.90 Mn |
| Sep 30, 2023 | 51.03 Mn |
| Jun 30, 2023 | 50.84 Mn |
| Mar 31, 2023 | 50.78 Mn |
| Dec 31, 2022 | 44.29 Mn |
| Sep 30, 2022 | 61.68 Mn |
| Jun 30, 2022 | 57.54 Mn |
| Mar 31, 2022 | 49.21 Mn |
| Dec 31, 2021 | 27.92 Mn |